Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Public ClinicalTrials.gov record NCT01623167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia
Study identification
- NCT ID
- NCT01623167
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Interventions
- Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 Drug
- Cohort 2: hATG, CsA, EPAG Day 14 to Month 3 Drug
- Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6 Drug
- Extension Cohort Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2012
- Primary completion
- Jan 29, 2018
- Completion
- Nov 29, 2029
- Last update posted
- Apr 12, 2026
2012 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01623167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01623167 live on ClinicalTrials.gov.